Announcements Trials

Browse Landscape

Phase

Phase 1 4 Phase 1/2 2 Phase 2 1

Status

Sponsor Class

INDUSTRY 5 OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Carcinoma, Transitional Cell 1

Interventions

Cisplatin 1038 Cyclophosphamide 972 Carboplatin 952 Radiotherapy 890 Bevacizumab 845 Gemcitabine 817 pembrolizumab 758 Paclitaxel 738 Docetaxel 733 Oxaliplatin 704 Capecitabine 646 Fluorouracil 563 Rituximab 559 Nivolumab 506 Dexamethasone 487 Etoposide 468 Doxorubicin 458 Irinotecan 442 Drug Therapy 400 Leucovorin 376 Cytarabine 342 Cetuximab 338 Lenalidomide 326 Trastuzumab 321 Pemetrexed 314 durvalumab 295 Filgrastim 287 Magnetic Resonance Spectroscopy 277 Temozolomide 275 Prednisone 273

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × OTHER × dactolisib × Clear all

NCT01856101 2019-04-10

BEZ235

Cliniques universitaires Saint-Luc- Université Catholique de Louvain

Phase 2 Terminated

Carcinoma, Transitional Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡